NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Caplight Logo









Embark Veterinary

Embark Veterinary

Private
Boston, MassachusettsHealthcare & Life Scienceshttps://www.embarkvet.com

Last Round

Series B

Jul 26, 2021

Est. Valuation

$700M

Total Funding Raised

$91.3M

Momentum Score

25 /100

Company Overview

Embark is a pet health and genetics company that offers a DNA testing kit to enhance dog health and wellness by tracking genetic markers and providing essential health information, including ancestry analysis and insights into genetic disease risk and heritable traits, all through a simple cheek swab.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, D2C Brands, Healthcare Analytics, Precision Medicine, Subscription Commerce

Business Model

B2C

Customer Profile

Hardware Sales, Hardware + Subscription, Services & Consulting

AI Layer

Application

Keywords

dog DNA testingpet DNA testingcanine genomicsgenetic health screeningdog breed identificationpet techDTC pet careveterinary genetic screeningbreeder DNA testingcanine health researchpersonalized pet carecomputational genomicsdog supplementsdog age testdog gut health testanimal health

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Embark Veterinary Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Embark Veterinary Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series BJul 26, 2021
Series AApr 10, 2019
SeedJul 18, 2017
SeedMay 31, 2016

Embark Veterinary Investors

Notable investors and investment history

InvestorRounds
Slow VenturesSeries B, Series A, Seed
S32Seed, Series A
SoftBank Investment AdvisersSeries B
SV AngelSeed, Series B
Founder CollectiveSeed
MaterialSeries A
F-Prime CapitalSeries B, Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 1, 2025

    Launched 'Long Stay, No Longer' initiative using DNA testing for shelter pets.

Embark Veterinary Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Embark Veterinary Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Embark Veterinary's valuation, stock price, and market status.

Firmographic Details

HeadquartersBoston, Massachusetts
Employee Range81
Year Founded2015
Last FundingJul 26, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.